Xylometazoline
Back to searchMolecule Structure
Scientific Name
Xylometazoline
Description of the Drug
Xylometazoline is a direct-acting alpha-adrenergic agonist used for the symptomatic treatment of nasal congestion and minor inflammation due to allergies or colds.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06694
http://www.drugbank.ca/drugs/DB06694
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha | PROTEIN FAMILY | AGONIST | CHEMBL2095203 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34087 | |
| PharmGKB | PA165958368 | |
| Human Metabolome Database | HMDB0015640 | |
| DrugBank | DB06694 | |
| PubChem: Thomson Pharma | 14823275 | |
| PubChem | 5709 | |
| Mcule | MCULE-9501725536 | |
| LINCS | LSM-5262 | |
| Nikkaji | J6.660E | |
| BindingDB | 30703 | |
| EPA CompTox Dashboard | DTXSID8046957 | |
| DrugCentral | 3658 | |
| ChemicalBook | CB0759137 | |
| Guide to Pharmacology | 517 | |
| rxnorm | XYLOMETAZOLINE HYDROCHLORIDE | XYLOMETAZOLINE |
| KEGG Ligand | C07913 | |
| ChEBI | 10082 | |
| ZINC | ZINC000000057534 |
